It appears as though the pharmaceutical juggernaut Eli Lilly is facing major legal backlash for failure to disclose discontinuation effects associated with their medication Cymbalta (Duloxetine). Cymbalta is an SNRI antidepressant that was approved in August 2004 for the treatment of major depression. A woman named Claudia Herrera has been making news headlines because she …
Cymbalta (Duloxetine) is a drug that us utilized primarily to treat major depression. It was approved in 2004 by the FDA as an SNRI antidepressant, and would later receive approval for the treatment of neuropathy, fibromyalgia, and some cases of chronic pain. The fact that Cymbalta can be prescribed to treat a diverse number of conditions …
If you have major depression, chances are good that you could name a few common antidepressants off the top of your head. When most people think of antidepressants, they think of the current most popular classes of medications: the SSRIs (Selective-Serotonin Reuptake Inhibitors) and the SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors). In particular, the SSRI “Prozac” seems …
The popularity of antidepressants has changed significantly over time. The first antidepressants called MAOIs were discovered in the 1950s and instantly became the most popular class. As newer tricyclic antidepressants emerged just a few years later, many of them were preferred over MAOIs because they carried less side effects and food interactions. The goal with …
SNRIs (Selective Serotonin Reuptake Inhibitors) are also known as dual-reuptake inhibitors because they prevent the reuptake of multiple neurotransmitters in the brain. Most of the second-generation antidepressants are classified as “SSRI,” meaning they focus solely on preventing the reuptake of serotonin. SNRI drugs continue to prevent the reuptake of serotonin, but also focus on another …
Research firm IMS Health has been collecting data on the number of prescriptions filled for certain drugs as well as the top selling drugs. The data that they collected was from July 2013 to June 2014; a full 12 months. From the lists of the top 100 drugs, I’ve narrowed it down to drugs that …
A newly released report from research firm IMS Health collected data on the most prescribed drugs in the United States from June 2013 to July 2014. Although the number one drug was Synthroid, a thyroid medication with over 22 million prescriptions, rounding out the top ten most prescribed were Cymbalta (#8), Vyvanse (#9), and Lyrica …